Jianhang Yin, PhD

Title(s)Postdoctoral Scholar, Microbiology and Immunology
SchoolSchool of Medicine
Phone--
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Peking University, Beijing, ChinaBachelor2016/07Biology
    Peking University, Beijing, ChinaPhD2022/07CRISPR and genome stability

    Collapse Research 
    Collapse Research Activities and Funding
    Cancer Research Institute

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cohesin maintains replication timing to suppress DNA damage on cancer genes. Nat Genet. 2023 08; 55(8):1347-1358. Wu J, Liu Y, Zhangding Z, Liu X, Ai C, Gan T, Liang H, Guo Y, Chen M, Liu Y, Yin J, Zhang W, Hu J. PMID: 37500731.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Safeguarding genome integrity during gene-editing therapy in a mouse model of age-related macular degeneration. Nat Commun. 2022 Dec 22; 13(1):7867. Yin J, Fang K, Gao Y, Ou L, Yuan S, Xin C, Wu W, Wu WW, Hong J, Yang H, Hu J. PMID: 36550137.
      View in: PubMed   Mentions: 8     Fields:    
    3. Comprehensive assessment of miniature CRISPR-Cas12f nucleases for gene disruption. Nat Commun. 2022 09 24; 13(1):5623. Xin C, Yin J, Yuan S, Ou L, Liu M, Zhang W, Hu J. PMID: 36153319; PMCID: PMC9509373.
      View in: PubMed   Mentions: 19     Fields:    Translation:Cells
    4. The origin of unwanted editing byproducts in gene editing. Acta Biochim Biophys Sin (Shanghai). 2022 May 25; 54(6):767-781. Yin J, Hu J. PMID: 35643959; PMCID: PMC9827802.
      View in: PubMed   Mentions: 4     Fields:    Translation:Cells
    5. Cas9 exo-endonuclease eliminates chromosomal translocations during genome editing. Nat Commun. 2022 Mar 08; 13(1):1204. Yin J, Lu R, Xin C, Wang Y, Ling X, Li D, Zhang W, Liu M, Xie W, Kong L, Si W, Wei P, Xiao B, Lee HY, Liu T, Hu J. PMID: 35260581; PMCID: PMC8904484.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    6. PEM-seq comprehensively quantifies DNA repair outcomes during gene-editing and DSB repair. STAR Protoc. 2022 03 18; 3(1):101088. Liu Y, Yin J, Gan T, Liu M, Xin C, Zhang W, Hu J. PMID: 35462794; PMCID: PMC9019705.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    7. Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates. Mol Cell. 2021 11 18; 81(22):4747-4756.e7. Ling X, Chang L, Chen H, Gao X, Yin J, Zuo Y, Huang Y, Zhang B, Hu J, Liu T. PMID: 34648747.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    8. Global detection of DNA repair outcomes induced by CRISPR-Cas9. Nucleic Acids Res. 2021 09 07; 49(15):8732-8742. Liu M, Zhang W, Xin C, Yin J, Shang Y, Ai C, Li J, Meng FL, Hu J. PMID: 34365511; PMCID: PMC8421148.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    9. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants. Nucleic Acids Res. 2021 09 07; 49(15):8785-8795. Zhang W, Yin J, Zhang-Ding Z, Xin C, Liu M, Wang Y, Ai C, Hu J. PMID: 34133740; PMCID: PMC8421146.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    10. Improved HTGTS for CRISPR/Cas9 off-target detection. Bio Protoc. 2019 May 05; 9(9):e3229. Yin J, Liu M, Liu Y, Hu J. PMID: 33655015; PMCID: PMC7854062.
      View in: PubMed   Mentions: 4  
    11. Optimizing genome editing strategy by primer-extension-mediated sequencing. Cell Discov. 2019; 5:18. Yin J, Liu M, Liu Y, Wu J, Gan T, Zhang W, Li Y, Zhou Y, Hu J. PMID: 30937179; PMCID: PMC6434046.
      View in: PubMed   Mentions: 39  
    12. CRISPR/Cas9-mediated targeted chromosome elimination. Genome Biol. 2017 Nov 24; 18(1):224. Zuo E, Huo X, Yao X, Hu X, Sun Y, Yin J, He B, Wang X, Shi L, Ping J, Wei Y, Ying W, Wei W, Liu W, Tang C, Li Y, Hu J, Yang H. PMID: 29178945; PMCID: PMC5701507.
      View in: PubMed   Mentions: 73     Fields:    Translation:AnimalsCells
    Jianhang's Networks
    Concepts (52)
    Derived automatically from this person's publications.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _